跳至主要内容
临床试验/CTRI/2026/02/103078
CTRI/2026/02/103078尚未招募2 期

A Randomized Controlled Trial to Evaluate the Chakshushya Effect of Ritu Haritaki Rasayana in Hemant Ritu in Presbyopic Population of Jaipur.

NATIONAL INSTITUTE OF AYURVEDA1 个研究点 分布在 1 个国家目标入组 74 人开始时间: 2026年8月9日最近更新:

试验速览

阶段
2 期
状态
尚未招募
入组人数
74
试验地点
1

研究概览

简要总结

Research Question:

Does Ritu Haritaki Rasayana have Chakshusya effect in Hemant Ritu with special reference to prevention of Presbyopia?

Hypothesis

Null Hypothesis [H0] There is no Chakshusya effect   of Ritu Haritaki Rasayana in Hemant Ritu with special refereance to prevention of presbyopia.

Alternative Hypothesis [HA] There is Chakshusya effect of Ritu Haritaki Rasayana in Hemant Ritu with special reference to prevention of presbyopia.

Aim

Evaluate the Chakshusya effect of Ritu Haritaki Rasayana in Hemant Ritu on Amplitudeof Accommodationin Presbyopic Population.

Objectives

Primary objective

To evaluate the effect of Ritu Haritaki as a Chakshushya Rasayan in Hemant Ritu on Amplitude of Accommodation in Presbyopic Population in NIA Jaipur.

Secondary objective

To assess the effect of Ritu Haritaki Rasayana in Hemant Ritu as a Chakshushya withrespect to Gross appearance of eye Colour vision*,* IOP, visual acuity,tear film stability in presbyopic population.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
35.00 Year(s) 至 55.00 Year(s)(—)
性别
All

入选标准

  • People of Age 35-55 years of either sex or religion Clinical features of presbyopia Difficulty in near vision Asthenopic symptoms Intermittent diplopia for near work.

排除标准

  • H/O hypersensitivity to the trial drug.
  • Patients having Diabetes and Hypertension.
  • Patients having lenticular or corneal opacity and with any other known ocular pathologies such as optic atrophy, diabetic retinopathy and hypertensive retinopathy.
  • History of recent surgical ocular intervention Contraindication of Haritaki consumption according to Acharya Charaka Ajirni Rukshabhuja Stri madya karshita Ardita Any other condition which the principal investigator thinks may jeopardize the study.

研究者

申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr. Vimleshi Meena

National Institute of Ayurveda

研究点 (1)

Loading locations...

相似试验